177 related articles for article (PubMed ID: 28447537)
1. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.
Arredondo A; Azar A; Recamán AL
Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537
[TBL] [Abstract][Full Text] [Related]
2. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
Arredondo A; Zúñiga A; Parada I
Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723
[TBL] [Abstract][Full Text] [Related]
3. Health disparities from economic burden of diabetes in middle-income countries: evidence from México.
Arredondo A; Reyes G
PLoS One; 2013; 8(7):e68443. PubMed ID: 23874629
[TBL] [Abstract][Full Text] [Related]
4. The cost of diabetes in Latin America and the Caribbean.
Barceló A; Aedo C; Rajpathak S; Robles S
Bull World Health Organ; 2003; 81(1):19-27. PubMed ID: 12640472
[TBL] [Abstract][Full Text] [Related]
5. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.
Bommer C; Heesemann E; Sagalova V; Manne-Goehler J; Atun R; Bärnighausen T; Vollmer S
Lancet Diabetes Endocrinol; 2017 Jun; 5(6):423-430. PubMed ID: 28456416
[TBL] [Abstract][Full Text] [Related]
6. [The cost of diabetes in Latin America: evidence from Mexico].
Arredondo A; De Icaza E
Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907
[TBL] [Abstract][Full Text] [Related]
7. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.
Barcelo A; Arredondo A; Gordillo-Tobar A; Segovia J; Qiang A
J Glob Health; 2017 Dec; 7(2):020410. PubMed ID: 29163935
[TBL] [Abstract][Full Text] [Related]
8. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.
Arredondo A; Zúñiga A
Diabetes Care; 2004 Jan; 27(1):104-9. PubMed ID: 14693974
[TBL] [Abstract][Full Text] [Related]
9. Trends and challenges in diabetes for middle-income countries: Evidence from Mexico.
Arredondo A; Orozco E; Duarte MB; Cuadra M; Recaman AL; Azar A
Glob Public Health; 2019 Feb; 14(2):227-240. PubMed ID: 30068257
[TBL] [Abstract][Full Text] [Related]
10. Universal coverage and economic burden from epidemiological changes of diabetes in Latin America.
Arredondo A
J Glob Health; 2016 Dec; 6(2):020309. PubMed ID: 28028433
[No Abstract] [Full Text] [Related]
11. Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.
Arredondo A; Duarte MB; Cuadra SM
Int J Health Plann Manage; 2017 Apr; 32(2):e121-e136. PubMed ID: 27238949
[TBL] [Abstract][Full Text] [Related]
12. Recent trends for the management of hypertension in older adults in Latin America in the context of universal coverage: Evidence from Mexico.
Arredondo A; Recamán AL; Suarez-Herrera JC; Cuadra SM
Int J Health Plann Manage; 2021 Mar; 36(2):579-586. PubMed ID: 33368667
[TBL] [Abstract][Full Text] [Related]
13. Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico.
Arredondo A; Zúñiga A
Am J Hypertens; 2006 Jun; 19(6):553-9. PubMed ID: 16733225
[TBL] [Abstract][Full Text] [Related]
14. Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030.
Bommer C; Sagalova V; Heesemann E; Manne-Goehler J; Atun R; Bärnighausen T; Davies J; Vollmer S
Diabetes Care; 2018 May; 41(5):963-970. PubMed ID: 29475843
[TBL] [Abstract][Full Text] [Related]
15. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.
Arredondo A; Aviles R
PLoS One; 2015; 10(3):e0118611. PubMed ID: 25781625
[TBL] [Abstract][Full Text] [Related]
16. Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine.
Arredondo A
BMC Med; 2014 Aug; 12():136. PubMed ID: 25266304
[TBL] [Abstract][Full Text] [Related]
17. Cost-of-illness studies in diabetes mellitus.
Ettaro L; Songer TJ; Zhang P; Engelgau MM
Pharmacoeconomics; 2004; 22(3):149-64. PubMed ID: 14871163
[TBL] [Abstract][Full Text] [Related]
18. [Direct and indirect diabetes costs in the world].
Logminiene Z; Norkus A; Valius L
Medicina (Kaunas); 2004; 40(1):16-26. PubMed ID: 14764977
[TBL] [Abstract][Full Text] [Related]
19. Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.
Arredondo A; Orozco E; Alcalde-Rabanal J; Navarro J; Azar A
Rev Saude Publica; 2018; 52():23. PubMed ID: 29489993
[TBL] [Abstract][Full Text] [Related]
20. Indirect costs of diabetes and its impact on the public finance: the case of Poland.
Torój A; Mela A
Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):93-105. PubMed ID: 28796563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
